Aileron Therapeutics's total assets for Q2 2024 were $109.40M, an increase of 10.29% from the previous quarter. ALRN total liabilities were $8.38M for the fiscal quarter, a 6.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.